GW24-e2961 A summary and evaluation of the current evidence for traditional Chinese medicine for myocardial infarction
Yue Wang(Anhui Medical University), Hongcai Shang(Beijing University of Chinese Medicine), Shuo Zhang(Beijing University of Chinese Medicine), Jingbo Zhai(Tianjin University of Traditional Chinese Medicine), Xiao Sun(Tianjin University of Traditional Chinese Medicine), Wei Mu(Tongji Hospital), Dongmei Xing(Tianjin University of Traditional Chinese Medicine), Xinzheng Lu(Tsinghua University)
Cited by 0
Related Papers
Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis
|Protein & Cell|2021|179
XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial
|Critical Care Medicine|2019|164
IL-10 Suppresses Chemokines, Inflammation, and Fibrosis in a Model of Chronic Renal Disease
|Journal of the American Society of Nephrology|2005|154
T regulatory cell function in idiopathic minimal lesion nephrotic syndrome
|Pediatric Nephrology|2009|140
In Vivo Administration of a Nuclear Transcription Factor-κB Decoy Suppresses Experimental Crescentic Glomerulonephritis
|Journal of the American Society of Nephrology|2000|114